Publication | Open Access
ROS1-fusion protein induces PD-L1 expression via MEK-ERK activation in non-small cell lung cancer
25
Citations
33
References
2020
Year
The correlation between ROS1-fusion and PD-L1 overexpression suggested that PD-L1/PD-1 blockade could be the second-line treatment option for the Crizotinib-resistant NSCLC with <i>ROS1</i> rearrangement.
| Year | Citations | |
|---|---|---|
Page 1
Page 1